Skip to content

Clinical trials

Lung Diseases trials in Romania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: Romania Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20111
20131
20142
20151
20162
20171
20192
20221
20232
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting5
Active, not recruiting2
Enrolling by invitation1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Novartis Pharmaceuticals4
Eli Lilly and Company3
United Therapeutics2
Celgene1
MediLink Therapeutics (Suzhou) Co., Ltd.1
Seagen, a wholly owned subsidiary of Pfizer1
Taiho Oncology, Inc.1
UMC Utrecht1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases19
Respiratory Tract Diseases10
Lung Diseases, Obstructive4
Pulmonary Disease, Chronic Obstructive4
Bronchial Diseases3
Carcinoma, Non-Small-Cell Lung3
Cystic Fibrosis3
Lung Neoplasms3
Thoracic Neoplasms3
Asthma2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.